Vaccine Use in Pregnancy
Start from the simplest idea. A vaccine is a rehearsal. It shows the immune system a harmless preview of a pathogen so that the body has already built memory by the time the real organism arrives. Everything else in this chapter is a consequence of that one sentence: the platforms are just different ways of staging the rehearsal safely, the timing rules are about when the memory and the antibody must already exist, and the contraindications are about which rehearsals are too realistic to stage during pregnancy.
What makes pregnancy special is that the rehearsal can protect two linked patients at once. A maternal vaccine can protect the mother from severe disease; it can protect the fetus indirectly by preventing maternal hypoxia, fever, viraemia or placental infection; and it can protect the newborn directly because the maternal antibody made in response to the vaccine is physically carried across the placenta into the fetal circulation. One injection, given to one person, can reach three different beneficiaries by three different mechanisms. That is the unifying logic to anchor on before any detail.
At this level, learn the mechanism — how a vaccine generates immunity, how that immunity is transferred, and how the risk-benefit logic works. Specific schedules, gestational windows and product-by-product indications change with the season and the guideline, so they are taught in the clinical chapters, especially Intermediatevaccines in pregnancy, Finalantenatal care and screening and Finalemerging pandemic disease in pregnancy. If you understand the mechanism, you can re-derive the right answer when the product or schedule changes.
How a Vaccine Actually Works
Before talking about pregnancy at all, build the immunology, because every later rule depends on it. The body has two defence layers. The innate system is always on standby: macrophages, neutrophils, dendritic cells and complement proteins recognise broad molecular patterns shared by many pathogens and react within minutes to hours, but they have no memory and do not improve with repeated exposure. The adaptive system is slower but specific and remembers. It is built on lymphocytes — B cells that make antibody, and T cells that either help organise the response (helper T cells) or kill virally infected cells (cytotoxic T cells).
The single most important fact for vaccination is immunological memory. The first time the adaptive system meets a new antigen, it has to find the rare cells that happen to recognise it and then multiply them, so it takes several days before useful antibody appears. This is the primary response. But after that response settles, some cells are kept in reserve as memory cells. The next time the same antigen appears, the secondary response is faster, larger and of higher quality. A vaccine deliberately triggers a safe primary response so that the dangerous real exposure is met by a ready-made secondary response instead. That is the entire point of a vaccine in one mechanism.
How does the body find the right cells? Through clonal selection. The body generates an enormous library of B cells before it has ever met any pathogen, each carrying a different randomly built antibody on its surface. When an antigen arrives, the few B cells whose antibody happens to fit it are switched on and divide into a clone. Most of that clone becomes plasma cells that pour out soluble antibody as the effector molecule; a minority become the long-lived memory cells. Over the response the clone also improves — the immune system mutates and re-selects the antigen-binding site so later antibody binds more tightly, a process called affinity maturation. So a good vaccine does not just raise an antibody level; it leaves behind both memory and a better-quality antibody.
| Immune concept | What it is | Why it matters for vaccines |
|---|---|---|
| Innate immunity | Fast, pattern-based, no memory | Provides the danger signals that "switch on" the adaptive response to a vaccine antigen |
| Adaptive immunity | Slow, specific, has memory | The layer a vaccine is actually training |
| Primary response | First, slow exposure to an antigen | The vaccine supplies this safely, ahead of real infection |
| Secondary response | Fast, strong response on re-exposure | The protective payoff at the real exposure |
| Clonal selection | Antigen picks and expands the matching B/T cells | Explains why protection is antigen-specific |
| Memory cells | Long-lived reserve after a response | The durable part of vaccine protection |
| Affinity maturation | Antibody quality improves over the response | Why a properly primed response neutralises better |
The Antibody Molecule, and Why the Fc Region Is the Key to Pregnancy
The effector molecule that does most of the protective work is the antibody (immunoglobulin). Its shape explains both how vaccines protect and how that protection reaches the fetus, so it is worth one careful look. An antibody is a Y-shaped protein of four chains — two heavy and two light. The two tips of the Y are the variable region: this is the part that differs between antibodies and that grips a specific antigen. The stalk of the Y is the constant region, and its base is called the Fc region.
This split — variable tips, constant stalk — does two jobs. The variable tips let antibody neutralise a pathogen by physically blocking it: anti-toxin antibody against tetanus or diphtheria works exactly this way, plugging the toxin so it cannot bind its target. The Fc stalk does everything else: it recruits help. Fc binds to Fc receptors on innate cells (macrophages, neutrophils) to flag a target for destruction (opsonisation), and it can trigger the complement cascade to punch holes in or tag a pathogen. So one antibody both marks the enemy and calls in the troops.
There are five antibody classes — IgM, IgG, IgA, IgE and IgD — distinguished by their constant region, and the differences are clinically decisive in pregnancy:
| Class | Key feature | Pregnancy relevance |
|---|---|---|
| IgG | The main, long-lived, high-affinity antibody; small enough and shaped to be actively transported | The ONLY class transported across the placenta in quantity — the basis of all neonatal passive immunity |
| IgM | Large, five units joined; made first in a response | Does NOT cross the placenta — so fetal/neonatal IgM signals the fetus made it, i.e. fetal infection |
| IgA | Found in mucosal secretions | The dominant antibody in colostrum and breast milk; protects the infant gut and respiratory mucosa |
| IgE | Binds mast cells | Drives allergic and anaphylactic reactions — relevant to vaccine allergy |
| IgD | Mostly a B-cell surface receptor | Little direct vaccine relevance |
Hold on to two facts, because the rest of the chapter rests on them: IgG is the class that crosses the placenta, and it crosses because of its Fc region. A vaccine that raises maternal IgG can therefore protect a newborn; the timing rules below are simply about getting enough of the right IgG made and transferred before the baby is born.
Active and Passive Protection
With the immunology in place, the first big distinction falls out naturally. There are two fundamentally different ways to make someone immune, and pregnancy vaccine questions constantly mix them up. Active protection trains the patient's own immune system to make the antibody and memory — that takes days to weeks but lasts. Passive protection hands over ready-made antibody — that works immediately but fades, because no memory is created. Maternal vaccination is a clever hybrid: the mother is immunised actively, and the IgG she makes is then transferred passively to her baby.
| Strategy | What is given | Immune result | Pregnancy example |
|---|---|---|---|
| Active immunisation | Antigen that stimulates the patient's immune system | Memory B cells, T cells and antibody after days to weeks | Influenza, Tdap/pertussis-containing, COVID-19, tetanus-containing vaccines |
| Passive immunisation | Ready-made antibody | Immediate but temporary protection; no immune memory | HBIG after hepatitis B exposure pathway; varicella-zoster immunoglobulin after exposure; anti-D for RhD prevention |
| Maternal passive transfer | Maternal IgG transported across placenta | Newborn has temporary antibody after birth | Pertussis and RSV maternal immunisation logic |
| Breast milk immune support | Mainly secretory IgA and immune factors at mucosa | Local gut/respiratory mucosal support, not systemic infant vaccine replacement | Breastfeeding-associated protection |
Mechanism chain for active immunisation:
antigen exposure -> innate immune activation -> antigen presentation -> clonal expansion -> plasma cells and memory cells -> faster, stronger secondary response at pathogen exposure.
Mechanism chain for neonatal passive protection:
maternal vaccine -> maternal IgG rise -> FcRn-mediated placental transfer -> infant serum antibody at birth -> early-life protection while infant immune responses mature.
Why Pregnancy Vaccination Works
Vaccines present antigen safely enough to generate adaptive immunity before pathogen exposure. In pregnancy the goal can be maternal, fetal, neonatal or public-health protection.
| Benefit | Immunological mechanism | O&G example |
|---|---|---|
| Maternal protection | Memory B/T cells and neutralising antibodies reduce infection or severe disease | Influenza and COVID-19 vaccination reduce severe respiratory disease risk |
| Fetal protection through maternal health | Avoids maternal hypoxia, shock, fever and systemic inflammation | Preventing severe influenza protects uteroplacental oxygen delivery |
| Neonatal passive immunity | Maternal IgG crosses placenta via FcRn receptors, especially later gestation | Pertussis vaccination protects young infants before their own vaccine series |
| Community protection | Reduced susceptibility, severity and sometimes transmission | Outbreak control and reduced household exposure |
| Health-system protection | Fewer admissions and critical-care needs | Important during seasonal influenza and pandemic waves |
